default author photo

Takehiro Ohnuma

Kumamoto Kenhoku Hospital

University of Yamanashi - Department of Dermatology

Yamanashi

Japan

National Cancer Center, Japan

SCHOLARLY PAPERS

3

DOWNLOADS

179

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Efficacy Comparison between Anti-PD-1 Antibody Monotherapy and Anti-PD-1 Plus Anti-CTLA-4 Combination Therapy as First-Line Immunotherapy for Advanced Acral Melanoma: A Retrospective, Multicenter Study of 254 Japanese Patients

Number of pages: 29 Posted: 22 Apr 2022
Saitama Medical University International Medical Center (SIMC) - Department of Skin Oncology/Dermatology, National Cancer Center Hospital, Shinshu University - Department of Dermatology, Nagoya City University, affiliation not provided to SSRN, Shizuoka Cancer Center, Jichi Medical University, affiliation not provided to SSRN, Niigata Cancer Center Hospital, Chiba Cancer Center - Research Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Kawasaki Medical School, affiliation not provided to SSRN, Iwate Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, Kumamoto Kenhoku Hospital, Kyoto University - Kyoto University Hospital, affiliation not provided to SSRN and National Cancer Center Hospital
Downloads 70 (875,328)
Citation 1

Abstract:

Loading...

acral melanomapalm and solenail apparatusanti-PD-1 antibodyanti-CTLA-4 antibodynivolumabpembrolizumabipilimumab

2.

PD-1 Blockade Therapy Promotes Novel Infiltration of Tumor-Specific T-Cell Clonotypes

Number of pages: 69 Posted: 02 Mar 2021
Okayama University, Chiba Cancer Center - Research Institute, KOTAI Biotechnologies, Inc., National Cancer Center - Division of Cancer Immunology, KOTAI Biotechnologies, Inc., National Cancer Center - Division of Cellular Signaling, National Cancer Center Research Institute, National Cancer Center - Division of Cancer Immunology, Chiba Cancer Center - Research Institute, University of Yamanashi - Department of Dermatology, Kumamoto Kenhoku Hospital, Chiba Cancer Center - Department of Thoracic Surgery, Chiba Cancer Center - Department of Thoracic Surgery, Chiba Cancer Center - Research Institute, Chiba Cancer Center - Department of Head and Neck Surgery, Chiba University - Department of Otolaryngology, Head and Neck Surgery, Nagoya University - Department of Immunology, University of Yamanashi - Department of Dermatology, Chiba University - Department of Dermatology, Osaka City University - Department of Hematology, National Cancer Center - Division of Cellular Signaling, University of Tokyo, Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, National Cancer Center, Japan and Chiba Cancer Center - Research Institute
Downloads 67 (899,324)

Abstract:

Loading...

tumor-specific T cell, exhausted T cell, neoantigen, tumor microenvironment, tumor-draining lymph node

3.

Immunopeptidomics Combined with Full-Length Transcriptomics Uncovers Diverse Cryptic Neoantigens

Number of pages: 56 Posted: 28 May 2025
Okayama University, Okayama University, Sapporo Medical University, Okayama University, Chiba Cancer Center - Research Institute, Okayama University, University of Tokyo - Graduate School of Frontier Science, University of Tokyo, Chiba University, Okayama University, Okayama University, Nagoya University, National Cancer Center Research Institute, National Cancer Center Research Institute, University of Yamanashi - Department of Dermatology, University of Yamanashi - Department of Dermatology, Kumamoto Kenhoku Hospital, Chiba University, Chiba University, KOTAI Biotechnologies, Inc., Chiba Cancer Center, Nagoya University - Graduate School of Medicine, National Cancer Center, Japan, Okayama University, Chiba University, Tokyo Medical and Dental University, University of Tokyo - Graduate School of Frontier Science, University of Tokyo, Graduate School of Frontier Sciences, Department of Computational Biology and Medical Sciences, National Cancer Center - Division of Cellular Signaling, Asahikawa Medical University, Sapporo Medical University, Chiba Cancer Center, Chiba Cancer Center - Research Institute and Independent
Downloads 42 (1,157,785)

Abstract:

Loading...

Cancer immunology, neoantigen, long-read RNA sequencing, HLA ligandome